Fourth triMS.online conference
The fourth triMS.online conference
21–22 October 2020
14:00–17:00 BST | 09:00–12:00 EDT | 15:00–18:00 CEST
The latest research and clinical insights on Looking ahead: the future of MS management
Themed sessions across two days
'Hot topic' debates on the topics:
The fourth triMS.online meeting took place across two days on 21−22 October 2020 on the theme Looking ahead: the future of MS management. Building on the current knowledge of the management of MS during the COVID-19 pandemic, the scientific programme will focus on treatment optimization and how the future of treatment for people with MS will be affected through the role of digital health and emerging therapies.
With a mixture of keynote presentations, plenary lectures, industry symposia and interactive Q&A and debate sessions, the faculty will deep-dive into the latest research and clinical insights across two days:
We are committed to creating an environment where healthcare professionals and researchers in the field of MS can discuss the latest information and network with fellow professionals free of charge and from the comfort of their home or workplace, without the need to travel.
We welcome the submission of abstracts for our conferences on the following topics:
Visit our ‘Submit an abstract’ page to complete the online form and submit your abstract for review by the Scientific Steering Committee.
| 13:30 |
Conference openFree time to explore the exhibition stands, poster hall and platinum sponsor theatre |
| 14:00 |
WelcomeJulia Pakpoor, UK (Chair) |
| 14:05 |
Live debateCOVID-19 will improve the future management of patients with MSJulia Pakpoor, UK (Chair) Gavin Giovannoni, UK Céline Louapre, France Douglas Sato, Brazil
|
| 14:25 |
Role of immunosuppressive therapies in MS and COVID-19Gavin Giovannoni, UK |
| 14:35 |
Impact of COVID-19 on managing pregnancy and MSLiliana Patrucco, Argentina
|
| 14:45 |
Q&AJulia Pakpoor, UK (Chair) Gavin Giovannoni, UK Liliana Patrucco, Argentina
|
| 14:50 |
Merck-sponsored satellite symposiumMS management: balancing benefit and risk in a new normalKlaus Schmierer, UK Celia Oreja-Guevara, Spain |
| 15:10 |
BreakFree time to explore the exhibit and poster halls |
| 15:30 |
The role of digital health in reshaping MS medical servicesIde Smets, UK |
| 15:40 |
The role of digital health in improving MS monitoring and researchJosé Flores-Rivera, Mexico
|
| 15:50 |
Q&AJulia Pakpoor (Chair) José Flores-Rivera, Mexico Ide Smets, UK |
| 16:05 |
Roche-sponsored satellite symposiumCOVID-19 and MS: can we draw conclusions for clinical practice?Gavin Giovannoni, UK |
| 16:25 |
Live debateShould patients with MS be vaccinated against COVID-19?Julia Pakpoor, UK (Chair) Gavin Giovannoni, UK Saúl Reyes Niño, UK Lana Zhovtis Ryerson, USA |
| 16:50 |
Meeting closeJulia Pakpoor, UK (Chair) |
| 13:30 |
Conference openFree time to explore the exhibition stands, poster hall and platinum sponsor theatre |
| 14:00 |
WelcomeFarrah Mateen, USA (Chair) |
| 14:05 |
Live debateCan we use anti-CD20 therapies as immune reconstitution therapies rather than maintenance therapies?Farrah Mateen, USA (Chair) Gavin Giovannoni, UK Monica Marta, UK Anders Svenningsson, Sweden |
| 14:30 |
Exploring the potential of BTK inhibitorsErin Longbrake, USA
|
| 14:40 |
Targeting macrophages: a novel therapeutic approach in MSClaire McCoy, Ireland |
| 14:50 |
Q&AFarrah Mateen, USA (Chair) Claire McCoy, Ireland
|
| 15:05 |
BreakFree time to explore the exhibit and poster halls
|
| 15:25 |
Should we be targeting inthrathecal plasma cells to treat MS?Sharmilee Gnanapavan
|
| 15:35 |
The effectiveness of S1PR modulators: an updateFrauke Zipp
|
| 15:45 |
Q&AFarrah Mateen, USA (Chair) Sharmilee Gnanapavan, UK Frauke Zipp, Germany
|
| 16:00 |
Bristol Myers Squibb-sponsored satellite symposiumQuantitative brain volume assessment: past, present, and futureMichael G. Dwyer, USA
|
| 16:20 |
Live discussionThe future of combination therapies in MSFarrah Mateen, USA (Chair) Gavin Giovannoni, UK Jorge Correale, Argentina Anna Williams, UK
|
| 16:50 |
Meeting closeFarrah Mateen, USA (Chair) |
 |
Fourth triMS.online Q&A 0.8MB PDF |
|
triMS.online day 1 speaker biographies 0.2MB PDF |
|
triMS.online day 2 speaker biographies 0.2MB PDF |
